The Latest Breaking News from TGA

Paracetamol is Australia’s most widely used pain medicine, with 65 million packs sold across the country in 2021. It is available everywhere from toilet vending machines, convenience stores, supermarkets, and pharmacies.

Australia’s drugs regulator issues 73 infringement notices over claims prescriptions could treat conditions such as cancer and epilepsy

In Victoria, Australian health officials are proposing to restrict permits currently allowing patients with mental illnesses to access psychedelics in a therapeutic framework back to research and clinical trials “app

The use of the injectable enzyme hyaluronidase has come under scrutiny amid calls for more industry regulation

Livestock producers are set to gain greater access to the pain relief products NumOcaine and Buccalgesic, used during castration, tail docking, and mulesing procedures.

When rapid antigen tests were handed out at her daughter's school in southern Sydney, Alyce Odams assumed they would be reliable. But when her family contracted COVID, the mother-of-two felt let down.

Australia's always been vulnerable to pharmaceutical shortages – but that vulnerability has been severely tested by the COVID-19 pandemic.

Moderna's bivalent vaccine is seen as the "next step" in COVID protection.

Strong job market and a slight decline in July inflation reading have raised investor optimism in the market. However, inflation still remains elevated, and the positive economic data might encourage the Fed to consider aggressive rate hikes. Since these factors are expected to keep the market volatile, it could be…

Whistleblower says he was instructed to tell customers the products were safe to consume, despite lack of testing evidence

The Fed’s aggressive interest rate hikes and the economy's contraction for two consecutive quarters have increased the odds of a potential recession. Nevertheless, robust corporate earnings and some positive economic data have greatly supported the downside of the benchmark indexes lately. Therefore, we think it could be wise to invest…